Sayaji Hotels Terminates Agreement with Wonder Leopard Retreat
Sayaji Hotels Limited has announced the termination of its hotel management agreement with Wonder Leopard Retreat Private Limited.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
3,484 articles published
Results for “INA” · in Corporate announcement — Clear filters
Sayaji Hotels Limited has announced the termination of its hotel management agreement with Wonder Leopard Retreat Private Limited.
Read articleSayaji Hotels Limited has announced termination of its hotel management agreement with Wonder Leopard Retreat Private Limited, as per a corporate filing with BSE.
Read articleSayaji Hotels Limited has announced termination of the hotel management agreement with Wonder Leopard Retreat Private Limited, as per BSE filing.
Read articleSayaji Hotels Limited has terminated its hotel management agreement with Wonder Leopard Retreat Private Limited, according to a BSE corporate filing.
Read articleSayaji Hotels Limited has announced the termination of its Hotel Management Agreement with Wonder Leopard Retreat Private Limited.
Read articleSayaji Hotels Limited has announced termination of its hotel management agreement with Wonder Leopard Retreat Private Limited, as per BSE filing.
Read articleSayaji Hotels Limited has terminated its hotel management agreement with Wonder Leopard Retreat Private Limited, according to a BSE corporate disclosure.
Read articleSayaji Hotels Limited has announced the termination of its hotel management agreement with Wonder Leopard Retreat Private Limited, according to a BSE corporate filing.
Read articleOrchid Pharma conducted its Q4 and full-year FY2026 earnings call with analysts and investors on May 26, 2026, reviewing performance for the quarter and financial year ended March 31, 2026.
Read articleOrchid Pharma has made the transcript of its Q4 and full-year FY2026 earnings call available. The call took place on May 26, 2026, covering the quarter and financial year ended March 31, 2026.
Read articleOrchid Pharma conducted its Q4 and FY2026 earnings call on May 26, 2026, covering performance for the quarter and financial year ending March 31, 2026.
Read articleOrchid Pharma conducted its Q4 and FY2026 earnings call with analysts and investors on May 26, 2026, covering the quarter and financial year ended March 31, 2026.
Read articleNureca Limited has submitted a corrigendum to its board meeting outcome originally filed on May 29, 2026, according to BSE filings. Details remain limited pending full disclosure.
Read articleNSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.